Why the study?
Does azosemide improve fluid index and thoracic impedance compared to furosemide in HFrEF patients with a CRT device?
Does azosemide improve fluid index and thoracic impedance compared to furosemide in HFrEF patients with a CRT device?
In HFrEF patients with CRT devices, long-acting loop diuretics (azosemide) and short-acting loop diuretics (furosemide) demonstrate comparable effects on device-measured fluid index and thoracic impedance.
No takes yet. Share an insight, caveat, or question.
Azosemide offers no advantage over furosemide for device fluid metrics in HFrEF with CRT; confirms comparable effects of long- versus short-acting loop diuretics.
Asami et al. (2017) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: